BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7740452)

  • 21. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass.
    Finn A; Naik S; Klein N; Levinsky RJ; Strobel S; Elliott M
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):234-41. PubMed ID: 8429650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation.
    Matsuzaki K; Hiramatsu Y; Homma S; Sato S; Shigeta O; Sakakibara Y
    Ann Thorac Surg; 2005 Aug; 80(2):611-7. PubMed ID: 16039215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro.
    Janciauskiene S; Zelvyte I; Jansson L; Stevens T
    Biochem Biophys Res Commun; 2004 Mar; 315(2):288-96. PubMed ID: 14766206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
    Renesto P; Chignard M
    J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation.
    Kappelmayer J; Bernabei A; Gikakis N; Edmunds LH; Colman RW
    J Lab Clin Med; 1993 Jan; 121(1):118-26. PubMed ID: 8426073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activation of granulocytes and antiproteases in open heart surgery].
    Welters ID; Hirsch J; Menzebach A; Hempelmann G; Müller M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Mar; 40(3):164-72. PubMed ID: 15770560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation.
    Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP
    J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of recombinant human factor XIII in a cynomolgus monkey model of extracorporeal blood circulation.
    Ponce R; Armstrong K; Andrews K; Hensler J; Waggie K; Heffernan J; Reynolds T; Rogge M
    Toxicol Pathol; 2005; 33(6):702-10. PubMed ID: 16243775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
    Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
    Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress during reperfusion of human hearts: potential sources of oxygen free radicals.
    Curello S; Ceconi C; de Giuli F; Panzali AF; Milanesi B; Calarco M; Pardini A; Marzollo P; Alfieri O; Messineo F
    Cardiovasc Res; 1995 Jan; 29(1):118-25. PubMed ID: 7895229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
    Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil chemotaxis in the horse is not mediated by a complex of equine neutrophil elastase and equine alpha-1-proteinase inhibitor.
    Scudamore CL; Pemberton A; Watson ED; Miller HR
    Br Vet J; 1993; 149(4):331-8. PubMed ID: 8221040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of activated protein C by recombinant alpha 1-antitrypsin variants with substitution of arginine or leucine for methionine358.
    Heeb MJ; Bischoff R; Courtney M; Griffin JH
    J Biol Chem; 1990 Feb; 265(4):2365-9. PubMed ID: 2298753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant antitrypsin Pittsburgh undergoes proteolytic cleavage during E. coli sepsis and fails to prevent the associated coagulopathy in a primate model.
    Harper PL; Taylor FB; DeLa Cadena RA; Courtney M; Colman RW; Carrell RW
    Thromb Haemost; 1998 Nov; 80(5):816-21. PubMed ID: 9843177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human plasma kallikrein releases neutrophil elastase during blood coagulation.
    Wachtfogel YT; Kucich U; James HL; Scott CF; Schapira M; Zimmerman M; Cohen AB; Colman RW
    J Clin Invest; 1983 Nov; 72(5):1672-7. PubMed ID: 6556194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin reduces monocyte and neutrophil CD11b up regulation in addition to blocking platelet activation during extracorporeal circulation.
    Rinder CS; Rinder HM; Smith MJ; Fitch JC; Tracey JB; Chandler WL; Rollins SA; Smith BR
    Transfusion; 2006 Jul; 46(7):1130-7. PubMed ID: 16836559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
    Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
    Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical significance of alpha 1-antitrypsin-elastase (alpha 1AT-ELP) and alpha 2-antiplasmin-plasmin (alpha 2AP-PL) complexes for the differentiation of coagulation protein turnover: indications for plasma protein substitution in patients with septicaemia.
    Seitz R; Egbring R; Radtke KP; Wolf M; Fuchs G; Fischer J; Lerch L; Karges HE
    Int J Tissue React; 1985; 7(4):321-8. PubMed ID: 2933357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.